ONCOSPAN

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Mar 2025 filing date already counts against anyone who files later.

Record

Serial number

99112500

Mark type

Stylized text

Filed

31 Mar 2025

Published for opposition

03 Feb 2026

Attorney of record

Kevin Oliver

Goods and services

• Class 001 — Chemicals: Biological preparations for laboratory, biopharmaceutical processing, and research purposes, for use as reference standards in science; Chemicals for use in the research of anti-cancer drugs; Biological preparations for quality control of laboratory research; Cell line-derived nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for use as reference standards for research purpose; Samples made of nucleic acids for use in biochemical or biological laboratory analysis for research purposes; Samples made of formalin and nucleic acids for use in a biochemical or biological laboratory analysis for research purposes; Samples made of formalin and cells for use in a biochemical or biological laboratory analysis for research purposes; Cell line-derived products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for scientific and research purposes, namely, for clinical investigations and for use in product testing; Reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for research purposes, namely, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing
• Class 005 — Pharmaceuticals: cell line-derived reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used in clinical medical samples; reference standard substances in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for clinical tests for medical purposes; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for detecting chromosomal abnormalities; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for analysing biological samples
• Class 040 — Treatment of materials: Custom manufacture of cell line-delivered products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for medical and commercial applications; Custom manufacture of reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids

Owner

• Revvity Discovery Limited, Cambridge, GB
• Revvity Discovery Limited, Cambridge, GB

Prosecution history

• 31 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 03 Feb 2026 — PUBLISHED FOR OPPOSITION
• 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 10 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 04 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 04 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 04 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 05 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 05 Sept 2025 — NON-FINAL ACTION E-MAILED
• 05 Sept 2025 — NON-FINAL ACTION WRITTEN
• 28 Aug 2025 — ASSIGNED TO EXAMINER
• 11 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 31 Mar 2025 — APPLICATION FILING RECEIPT MAILED
• 31 Mar 2025 — NEW APPLICATION ENTERED